Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $413,609 (100.0% shares, 0.0% debt)

Holdings (9)

BVS BIOVENTUS 41.2%

Value ($000) $170,563 Shares 12,096,702 Est. Cost $14.24 Unrealized -6.0%

MDXG MIMEDX GROUP, INC. 26.7%

Value ($000) $110,287 Shares 23,415,584 Est. Cost $7.34 Unrealized -33.4%

EYPT EYEPOINT PHARMACEUTICALS INC 12.3%

Value ($000) $50,920 Shares 4,190,921 Est. Cost $4.68 Unrealized +134.2%

TELA TELA BIO, INC. 9.3%

Value ($000) $38,568 Shares 3,316,236 Est. Cost $12.66 Unrealized -4.3%

— VENUS CONCEPT, INC. 5.6%

Value ($000) $23,363 Shares 21,169,457 Est. Cost $2.99 Unrealized —

— REVANCE THERAPEUTICS INC 2.2%

Value ($000) $8,913 Shares 457,085 Est. Cost $31.50 Unrealized —

— SONENDO INC 1.9%

Value ($000) $7,990 Shares 1,992,526 Est. Cost $5.76 Unrealized —

MNOV MEDICINOVA INC 0.7%

Value ($000) $2,953 Shares 1,105,941 Est. Cost $2.95 Unrealized -16.9%

— CATALYST BIOSCIENCES INC 0.0%

Value ($000) $52 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BVS	BIOVENTUS	12,096,702	$170,563	41.2%	$14.24	-6.0%	COM CL A	09075A108
MDXG	MIMEDX GROUP, INC.	23,415,584	$110,287	26.7%	$7.34	-33.4%	COM	602496101
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$50,920	12.3%	$4.68	+134.2%	COM NEW	30233G209
TELA	TELA BIO, INC.	3,316,236	$38,568	9.3%	$12.66	-4.3%	COM	872381108
—	VENUS CONCEPT, INC.	21,169,457	$23,363	5.6%	$2.99	—	COM	92332W105
—	REVANCE THERAPEUTICS INC	457,085	$8,913	2.2%	$31.50	—	COM	761330109
—	SONENDO INC	1,992,526	$7,990	1.9%	$5.76	—	COM	835431107
MNOV	MEDICINOVA INC	1,105,941	$2,953	0.7%	$2.95	-16.9%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$52	0.0%	$7.36	—	COM NEW	14888D208